Suntanning and risk of cutaneous melanoma: A literature review;Bronzeamento e risco de melanoma cutâneo: Revisão da literatura

Revista de Saude Publica

Volumn 38, Issue 4, 2004, Pages 588-598

  de Souza, Sonia R P ^a   Fischer, Frida M ^a   de Souza, José M P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Databases, bibliographic; Environmental exposure; Health knowledge, attitudes, practice; Melanoma, epidemiology; Melanoma, prevention control; Research; Ultraviolet rays, adverse affects

Indexed keywords

ATTITUDE; AWARENESS; CANCER RISK; CARCINOGENESIS; EMBASE; EPIDEMIOLOGICAL DATA; ESTHETICS; HABIT; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; HUMAN RELATION; INFORMATION DISSEMINATION; MASS MEDIUM; MEDICAL LITERATURE; MEDLINE; MELANOMA; MOTIVATION; PREVALENCE; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SKIN COLOR; SKIN DEFECT; SKIN PROTECTION; SOLAR RADIATION; SUN EXPOSURE; SUNBURN; ULTRAVIOLET RADIATION;

EID: 4644308916     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102004000400018     Document Type: Review

References (100)

1. Akslen LA, Morkve O. Expression of p53 protein in cutaneous melanoma. Int J Cancer 1992;52:13-6.
2. Arthey S, Clarke VA. Suntanning and sun protection: a review of the psychological literature. Soc Sci Med 1995;40:265-74.
3. Atillasoy ES, Seykora JT, Soballe PW, Elenitsas R, Nesbit M, Elder DE et al. UVB induces atypical melanocytic lesions and melanoma in human skin. Am J Pathol 1998;152:1179-86.
4. Autier P, Doré JF, Gefeller O, Cesarini JP, Lejeune F, Koelmel KF et al. Melanoma risk and residence in sunny areas. Br J Cancer 1997;76:1521-4.
5. Autier P, Doré JF, Lejeune F, Koelmel KF, Geffeler O, Hille P et al. Cutaneous malignant melanoma and exposure to sunlamps o sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. Int J Cancer 1994;58:809-13.
6. Autier P, Doré JF, Négrier S, Liénard D, Panizzon R, Lejeune FJ et al. Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst 1999;91:1304-9.
7. Autier P, Doré JF, Cattaruzza MS, Renard F, Luther H, Gentiloni-Silverj et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. J Natl Cancer Inst 1998;90:1873-80.
8. Balzi D, Carli P, Giannotti B, Buiatti E. Skin melanoma in Italy: a population-based study on survival and prognostic factors. Eur J Cancer 1998;34:699-704.
9. Bataille V, Grulich A, Sasieni P, Swerdlow A, Bishop JN, McCarthy W et al. The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer 1998;77:505-10.
10. Beral V, Robinson N. The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Br J Cancer 1981;44:886-91.
11. Blum HF. Sunlight and cancer of the skin. J Natl Cancer Inst 1940;1:397-421.
12. Blum HF. Sunlight as a causal factor in cancer of the skin of man. J Natl Cancer Inst 1948;9:247-58.
13. Boldeman C, Jansson B, Nilsson B, Ullen H. Sunbed use in Swedish urban adolescents related to behavioral characteristics. Prev Med 1997;26:114-9.
14. Brandberg Y, Jonell R, Broberg M, Sjödén PO, Rosdahl I. Sun-related behaviour in individuals with dysplasic naevus syndrome. Acta Derm Venereol 1996;76:381-4.
15. Brodland DG. The life of a skin cancer. Mayo Clin Proc 1997;72:475-8.
16. Buettner P, Raasch B. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998;78:587-93.
17. Bulliard JL, Cox B, Elwood JM. Comparison of the site distribution of melanoma in New Zealand and Canada. Int J Cancer 1997;72:231-5.
18. Bulliard JL, Cox B , Semeneiw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control 1999;10:407-16.
19. Burton RC, Coates MS, Hersey P, Roberts G, Chetty MP, Chen S et al. An analysis of a melanoma epidemic. Int J Cancer 1993;55:765-70.
20. Carli P, Biggeri A, Nardini P, De Giorgi V, Giannotti B. Sun exposure and large numbers of common and atypical melanocytic naevi: an analytical study in a southern European population. Br J Dermatol 1998;138:422-5.
21. Castanet J, Ortonne JP. Pigmentary changes in aged and photoaged skin. Arch Dermatol 1997;133:1296-9.
22. Castle CM, Skinner TC, Hampson SE. Young women and suntanning: an evaluation of a health education leaflet. Psychol Health 1999;14:517-27.
23. Chen YT, Dubrow R, Zheng T, Barnhill RL, Fine J, Berwick M. Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol 1998;27:758-65.
24. Chen YT, Zheng T, Holford T, Berwick M, Dubrow R. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 1994;5:341-50.
25. Clarke VA, Williams T, Arthey S. Skin type and optimistic bias in relation to the sun protection and suntanning behaviors of young adults. J Behav Med 1997;20:207-22.
26. Coleman WP, Loria PR, Reed RJ, Krementz ET. Acral lentiginous melanoma. Arch Dermatol 1980;116:773-6.
27. Cress RD, Holly EA, Ahn DK, LeBoit PE, Sagebiel RW. Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype. Cancer Epidemiol Biomakers & Prev 1995;4:831-6.
28. Cress RD, Holly EA, Ahn DK. Cutaneous melanoma in women. V. Characteristics of those who tan and those who burn when exposed to summer sun. Epidemiol 1995;6:538-43.
29. Davies RJH. Ultraviolet radiation damage in DNA. Sci Am 1996;275:38-43.
30. Diffey BL, McKinlay AF. The UVB content of 'UVA fluorescent lamps' and its erythemal effectiveness in human skin. Phys Med Biol 1983;28:351-8.
31. Diffey BL, Kerwin M, Davis A. The anatomical distribution of sunlight. Br J Dermatol 1977;97:407-9.
32. Douglass HM, McGee R, Williams S. Sun behaviour and perceptions of risk for melanoma among 21-year-old New Zealanders. Aust N Z J Public Health 1997;21:329-34.
33. Elder D. Tumor progression, early diagnosis and prognosis of melanoma. Acta Oncol 1999;38:535-47.
34. Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun-exposure. Int J Cancer 1998;78:276-80.
35. Elwood JM, Gallagher RP, Pearson JCG. Cutaneous melanoma in relation to intermittent and constant sun exposure - the Western Canada Melanoma Study. Int J Cancer 1985;35:427-33.
36. Elwood JM, Gallagher RP, Hill GB, Spinelli JJ, Pearson JCG, Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. BMJ 1984:288:99-102.
37. Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 1990;19:801-10.
38. Fairchild AL, Gemson DH. Safety information provided to customers of New York City suntanning salons. Am J Prev Med 1992;8:381-3.
39. Freeman SE, Gange RW, Sutherland JC, Sutherland BM. Pyrimidine dimer formation in the human skin. Photochem Photobiol 1987;46:207-12.
40. Gies HP, Roy CR, Toomey S, MacLennan R, Watson M. Solar UVR exposures of three groups of outdoor workers on the Sunshine Coast, Queensland. Photochem Photobiol 1995;6:1015-21.
41. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ 1996;312:1121-5.
42. Gontijo S. 80 anos de moda no Brasil. Rio de Janeiro: Editora Nova Fronteira; 1987.
43. Goodman KJ, Bible ML, London S, Mack TM. Proportional melanoma incidence and occupation among white males in Los Angeles County (California, United States). Cancer Causes Control 1995;6:451-9.
44. Green A, MacLennan R, Youl P, Martin N. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993;53:232-6.
45. Green A, Siskind V, Bain C, Alexander J. Sunburn and malignant melanoma. Br J Cancer 1985;51:393-7.
46. Harris CC. P53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ Health Perspect 1996;104(Suppl 3):435-9.
47. Helander SD, Peters MS, Pittelkow MR. Expression of p53 protein in benign and malignant epidermal pathologic conditions. J Am Acad Dermatol 1993;29:741-8.
48. Herlihy E, Gies PH, Roy CR, Jones M. Personal dosimetry of solar UV radiation for different outdoor activities. Photochem Photobiol 1994;3:288-94.
49. Hillhouse JJ, Adler CM, Drinnon J, Turrisi R. Application of Azjen's theory of planned behavior to predict sunbathing, tanning salon use, and sunscreen use intentions and behaviors. J Behav Med 1997;20:365-78.
50. Hillhouse JJ, Stair AW, Adler CM. Predictors of sunbathing and sunscreen use in college undergraduates. J Behav Med 1996;19:543-61.
51. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen J. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995;141:923-33.
52. Holman CDJ, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986;76:403-14.
53. International Agency for Research on Cancer. Solar and ultraviolet radiation. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 55. Lyon; 1992.
54. Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst 2000;92:811-8.
55. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001;93:678-83.
56. Jimbow K, Quevedo WC, Fitzpatrick TB, Szabó G. Biology of Melanocytes. In: Fitzpatrick TB et al., editors. Dermatology in general medicine. 4th ed. New York: MacGraw-Hill; 1993. p. 261-89.
57. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 1998;111:757-61.
58. Karlsson P, Boeryd B, Sander B, Westermark P, Rosdahl I. Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92. Acta Dermatol Venereol 1998;78:276-80.
59. Keesling B, Friedman HS. Psychosocial factors in sunbathing and sunscreen use. Health Psychol 1987;6:477-93.
60. Kennedy C, Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117:294-300.
61. Kirkpatrick CS, Lee JAH, White E. Melanoma risk by age and socioeconomic status. Int J Cancer 1990;46:1-4.
62. Kvam E, Tyrrell RM. The role of melanin in the induction of oxidative DNA base damage by ultraviolet A irradiation of DNA or melanoma cells. J Invest Dermatol 1999;113:209-13.
63. Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M et al. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 2002;94:94-101.
64. Leffell DJ, Brash DE. Sunlight and the skin cancer. Int J Cancer 1997;72:231-5.
65. Ley RD, Applegate LA, Padilla RS, Stuart TD. Ultraviolet radiation-induced malignant melanoma in Monodelphis domestica. Photochem Photobiol 1989;50:1-5.
66. Ley RD. Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica. Cancer Res 1997;57:3682-4.
67. MacKie RM, Hole DJ. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. BMJ 1996;312:1125-8.
68. McCarthy EM, Ethridge KP, Wagner RF. Beach holiday sunburn: the sunscreen paradox and gender differences. Cutis 1999;64:37-42.
69. McGinley J, Martin CJ, MacKie RM. Sunbeds in current use in Scotland: a survey of their output and patterns of use. Br J Dermatol 1998;139:428-38.
70. McGregor JM, Yu C C-W, Dublin EA, Levison DA, MacDonald DM. Aberrant expression of p53 tumour-supressor protein in non-melanoma skin cancer. Br J Dermatol 1992;127:463-9.
71. Melia J, Bulman A. Sunburn and tanning in a British population. J Pub Health Med 1995;17:223-9.
72. Miller AS, Hamilton SL, Wester UG, Cyr WH. An analysis of UVA emissions from sunlamps and potential importance for melanoma. Photochem Photobiol 1998;68:63-70.
73. Nelemans PJ, Groenendal H, Kiemeney LALM, Rampen FHJ, Ruiter DJ, Verbeek ALM. Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 1993;101:252-5.
74. Osterlind A, Hou-Jensen K, Jensen M. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 1988;58:385-91.
75. Pathak MA, Fitzpatrick TB. Preventive treatment of sunburn, dermatoheliosis, and skin cancer with sunprotective agents. In: Fitzpatrick TB et al, editors. Dermatology in general medicine. 4th ed. New York: MacGraw-Hill; 1993. p. 1689-717.
76. Pion IA, Rigel DS, Garfinkel L, Silverman MK, Kopf AW. Occupation and the risk of malignant melanoma. Cancer 1995;75:637-44.
77. Randle HW. Suntanning: differences in perceptions throughout History. Mayo Clin Proc 1997;72:461-6.
78. Rhainds M, De Guire L, Claveau J. A population-based survey on the use of artificial tanning devices in the Province of Qué bec, Canada. J Am Acad Dermatol 1999;40:572-6.
79. Ro YS, Cooper PN, Lee JA, Quinn AG, Harrison D, Lane D et al. p53 protein expression in benign and malignant skin tumours. Br J Dermatol 1993;128:237-41.
80. Robinson JK, Rigel DS, Amonette RA. Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol 1997;37:179-86.
81. Ródenas JM, Delgado-Rodríguez M, Farinas-Alvarez C, Herranz MT, Serrano S. Melanocytic nevi and risk of cutaneous malignant melanoma in Southern Spain. Am J Epidemiol 1997;145:1020-9.
82. Ródenas JM, Delgado-Rodríguez M, Herranz MT, Tercedor J, Serrano S. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control 1996;7:275-83.
83. Rünger TM, Epe B, Möller K. Processing of directly and indirectly ultraviolet-induced DNA damage in human cells. Recent Results Cancer Res 1995;139:31-41.
84. Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993;90:6666-70.
85. Slominski A, Ross J, Mihm MC. Cutaneous melanoma: pathology, relevant prognostic indicators and progression. Br Med Bull 1995;51:548-69.
86. Sober AJ, Burstein JM. Computerized digital image analysis: an aid for melanoma diagnosis - preliminary investigations and brief review. J Dermatol 1994;21:885-90.
87. Souza SRP. Tendência temporal da mortalidade por melanoma cutâneo no Estado de São Paulo, 1979-1998 [tese de doutorado]. São Paulo: Faculdade de Saúde Pública da USP; 2001.
88. Vagerö D, Ringbäck G, Kiviranta H. Melanoma and other tumours of the skin among office, other indoor and outdoor workers in Sweden 1961-1979. Br J Cancer 1986;53:507-12.
89. Van der Spek-Keijser LMT, Van der Rhee HJ, Tóth G, Van Westering R, Bruijn J A, Coebergh JWW. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol 1997;136:565-71.
90. Walter SD, Marret LD, From L, Hertzman C, Shannon HS, Roy P. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 1990;131:232-43.
91. Warmer GW, Wei RR. In vitro photooxidation of nucleic acids by ultraviolet A radiation. Photochem Photobiol 1997;65:560-3.
92. Westerdahal J, Olsson H, Masback A, Ingvar C, Jonsson N, Brandt L et al. Use of sunbeds or sunlamps and malignant melanoma in Southern Sweden. Am J Epidemiol 1994;140:691-9.
93. Westerdahl J, Ingvar C, Masback A, Olsson H. Sunscreen use and malignant melanoma. Int J Cancer 2000;87:145-50.
94. Westerdahl J, Olsson H, Ingvar C. At what age do sunburn episodes play a crucial role for the development of malignant melanoma. Eur J Cancer 1994;30A:1647-54.
95. White E, Kirkpatrick CS, Lee JAH. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 1994;139:857-68.
96. Wichstrom L. Predictors of Norwegian adolescents' sunbathing and use of sunscreen. Health Psychol 1994;5:412-20.
97. World Health Organization. Ultraviolet radiation. Environmental health criteria 160. Geneva; 1994.
98. Wünsch Filho V, Moncau JE. Mortalidade por câncer no Brasil 1980-1995: padrões regionais e tendências temporais. Rev Assoc Med Bras 2002;48:250-7.
99. Young A, Potten CS, Nikaido O, Parsons PG, Boenders J, Ramsden M et al. Human melanocytes and keratinocytes exposed to UVB or UVA in vivo show comparable levels of thymine dimers. J Invest Dermatol 1999;111:936-40.
100. Young AR. Chromophores in human skin. Phys Med Biol 1997;42:789-802.